Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1–7 trials

  1. Aroda, V.R.
  2. Ahmann, A.
  3. Cariou, B.
  4. Chow, F.
  5. Davies, M.J.
  6. Jódar, E.
  7. Mehta, R.
  8. Woo, V.
  9. Lingvay, I.
Zeitschrift:
Diabetes and Metabolism

ISSN: 1878-1780,  1262-3636

Datum der Publikation: 2019

Ausgabe: 45

Nummer: 5

Seiten: 409-418

Art: Rezension

DOI: 10.1016/J.DIABET.2018.12.001 GOOGLE SCHOLAR
Datenquelle: Scopus